世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035862

医薬品製造受託機関(CMO)の世界市場規模調査・予測:サービスタイプ別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Size study & Forecast, by Service Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing) and Regional Analysis, 2022-2029

発刊日 2023/05/09

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000035862

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

製造委託とは、製造業者が他の製造業者と正式な契約を結び、その部品や商品、コンポーネントを調達するアウトソーシングのことです。医薬品製造受託機関(CMO)は、製薬業界を対象とした組織で、製造から医薬品研究までの全サービスを顧客に提供します。CMOは、医薬品の開発から製造、包装、ラベル付け、流通に至るまで、顧客にサービスを提供します。クライアントである製薬会社は、CMOにアウトソーシングすることで、オーバーヘッドを発生させることなく、技術リソースを拡大することができます。インフラや技術者を増減することなく、中核となる能力や価値の高いプロジェクトに集中することで、クライアントは社内のリソースやコストを管理することができます。インフラストラクチャーや技術者を減らしたり増やしたりせず、中核となる能力や価値の高い取り組みに集中することで、事業者は社内のコストやリソースを管理することができます。市場の成長は、主にジェネリック医薬品の需要の急増、製薬会社によるアウトソーシング量の増加、様々な疾患の有病率の増加などの要因によってもたらされます。

また、製薬業界全体の研究開発活動への投資拡大が、全世界の市場成長において重要な役割を果たしています。Statistaによると、2020年の製薬業界における研究開発費の総額は1,980億米ドルで、2025年には約2,480億米ドルに達すると予測されています。結果的に、これらの前述した要因が市場の世界の開拓を牽引しています。さらに、政府のイニシアティブの高まりや、新興国での事業拡大が、予測される数年間にさまざまな有利な機会をもたらしています。しかし、厳しい規制要件、リードタイムと物流コストの増加が、2022年から2029年の予測期間を通じて市場の成長に影響を与えています。

世界の医薬品製造受託機関(CMO)市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、および世界のその他の地域含まれます。北アメリカは、高度な製造能力の存在とともに、同地域での臨床試験件数の増加により、収益面で市場を独占しています。一方、アジア太平洋地域は、有利な政府政策、研究開発投資の増加、製薬会社によるアウトソーシングの増加などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。

調査範囲

  • 調査企業
    ➣ Catalent Inc.
    ➣ Recipharm AB
    ➣ Jubilant Biosys Ltd. (Jubilant Pharmova Ltd)
    ➣ Patheon Inc. (Thermo Fisher Scientific Inc.)
    ➣ Boehringer Ingelheim Group
    ➣ Pfizer CentreSource (Pfizer Inc.)
    ➣ Aenova Group
    ➣ Famar SA
    ➣ Baxter Biopharma Solutions (Baxter International Inc.)
    ➣ Lonza Group AG
  • 調査対象年
    ➣ 履歴データ - 2019-2020-2021
    ➣ 推定基準年 - 2021
    ➣ 予測期間 - 2022-2029

この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。

このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。

  • 市場セグメント
    ➣ サービスタイプ別
      ◇ 原薬(API)製造
      ◇ 最終製剤(FDF)開発・製造
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ その他のラテンアメリカ
      ◇ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Service Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Dynamics
3.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising outsourcing volume by pharmaceutical companies
3.1.1.2. Growing investment in research and development activities across the pharmaceutical industry
3.1.2. Market Challenges
3.1.2.1. Stringent regulatory requirements
3.1.2.2. Increasing lead time and logistics costs
3.1.3. Market Opportunities
3.1.3.1. Rising number of government initiatives
3.1.3.2. Expansion in emerging countries

Chapter 4. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Service Type
6.1. Market Snapshot
6.2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by Service Type, Performance - Potential Analysis
6.3. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Estimates & Forecasts by Service Type 2019-2029 (USD Billion)
6.4. Pharmaceutical Contract Manufacturing Organization (CMO) Market, Sub Segment Analysis
6.4.1. Active Pharmaceutical Ingredient (API) Manufacturing
6.4.2. Finished Dosage Formulation (FDF) Development and Manufacturing

Chapter 7. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, Regional Analysis
7.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market, Regional Market Snapshot
7.2. North America Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.2.1. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.2.1.1. Service Type breakdown estimates & forecasts, 2019-2029
7.2.2. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3. Europe Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
7.3.1. U.K. Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.2. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.3. France Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.4. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.5. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3.6. Rest of Europe Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4. Asia-Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
7.4.1. China Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.2. India Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.3. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.4. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.5. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4.6. Rest of Asia Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.5. Latin America Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
7.5.1. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.5.2. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.5.3. Rest of Latin America Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.6. Rest of The World Pharmaceutical Contract Manufacturing Organization (CMO) Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Catalent Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Recipharm AB
8.2.3. Jubilant Biosys Ltd. (Jubilant Pharmova Ltd)
8.2.4. Patheon Inc. (Thermo Fisher Scientific Inc.)
8.2.5. Boehringer Ingelheim Group
8.2.6. Pfizer CentreSource (Pfizer Inc.)
8.2.7. Aenova Group
8.2.8. Famar SA
8.2.9. Baxter Biopharma Solutions (Baxter International Inc.)
8.2.10. Lonza Group AG

Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, report scope
TABLE 2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by Service Type 2019-2029 (USD Billion)
TABLE 4. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Pharmaceutical Contract Manufacturing Organization (CMO) Market
TABLE 69. List of primary sources, used in the study of global Pharmaceutical Contract Manufacturing Organization (CMO) Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, research methodology
FIG 2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, key trends 2021
FIG 5. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, growth prospects 2022-2029
FIG 6. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, porters 5 force model
FIG 7. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, pest analysis
FIG 8. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, value chain analysis
FIG 9. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, regional snapshot 2019 & 2029
FIG 15. North America Pharmaceutical Contract Manufacturing Organization (CMO) Market 2019 & 2029 (USD Billion)
FIG 16. Europe Pharmaceutical Contract Manufacturing Organization (CMO) Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Pharmaceutical Contract Manufacturing Organization (CMO) Market 2019 & 2029 (USD Billion)
FIG 19. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000035862

TOP